Sight Sciences Company Insiders
SGHT Stock | USD 2.49 0.03 1.22% |
Slightly above 72% of Sight Sciences' corporate insiders are selling. The analysis of insiders' sentiment of trading Sight Sciences stock suggests that many insiders are alarmed at this time. Sight Sciences employs about 214 people. The company is managed by 20 executives with a total tenure of roughly 500 years, averaging almost 25.0 years of service per executive, having 10.7 employees per reported executive.
Insider Sentiment 28
Mostly Selling
Selling | Buying |
Latest Trades
2025-01-17 | David Badawi | Disposed 5423 @ 2.78 | View | ||
2025-01-16 | Paul Badawi | Disposed 24819 @ 2.92 | View | ||
2025-01-08 | Jeremy B Hayden | Disposed 1810 @ 3.26 | View | ||
2025-01-03 | Jeremy B Hayden | Disposed 4864 @ 3.52 | View | ||
2025-01-02 | Paul Badawi | Disposed 12236 @ 3.6 | View | ||
2024-12-06 | Manohar K Raheja | Acquired 5000 @ 3.85 | View | ||
2024-12-03 | Manohar K Raheja | Acquired 3376 @ 3.89 | View | ||
2024-11-29 | Manohar K Raheja | Acquired 4624 @ 3.99 | View | ||
2024-11-19 | Manohar K Raheja | Acquired 2000 @ 3.7 | View | ||
2024-10-21 | Matthew Link | Disposed 21831 @ 5.61 | View | ||
2024-10-18 | Matthew Link | Disposed 20487 @ 5.98 | View | ||
2024-10-16 | Matthew Link | Disposed 20734 @ 5.91 | View | ||
2024-10-02 | Paul Badawi | Disposed 12727 @ 5.99 | View | ||
2024-10-01 | Sam Boong Park | Disposed 3403 @ 6.08 | View |
Monitoring Sight Sciences' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Sight |
Sight Sciences Management Team Effectiveness
The company has return on total asset (ROA) of (0.1941) % which means that it has lost $0.1941 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4536) %, meaning that it created substantial loss on money invested by shareholders. Sight Sciences' management efficiency ratios could be used to measure how well Sight Sciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.31 in 2025. Return On Capital Employed is likely to drop to -0.35 in 2025. At this time, Sight Sciences' Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 4.4 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 11.6 M in 2025.Common Stock Shares Outstanding is likely to drop to about 49.4 M in 2025. Net Loss is likely to gain to about (73.7 M) in 2025
Sight Sciences Workforce Comparison
Sight Sciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 19,461. Sight Sciences claims roughly 214 in number of employees contributing just under 2% to equities under Health Care industry.
Sight Sciences Profit Margins
The company has Profit Margin (PM) of (0.63) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.56) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.56.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.61 | 0.77 |
|
|
Sight Sciences Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sight Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sight Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Sight Sciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 0.7 | 7 | 10 | 822,802 | 670,129 |
2024-06-01 | 1.0 | 6 | 6 | 104,196 | 47,195 |
2023-12-01 | 7.0 | 14 | 2 | 2,409,118 | 3,002,036 |
2023-09-01 | 1.0 | 2 | 2 | 37,668 | 37,668 |
2023-03-01 | 2.125 | 17 | 8 | 968,400 | 22,753 |
2022-09-01 | 0.3333 | 1 | 3 | 40,000 | 4,426,670 |
2022-06-01 | 7.0 | 7 | 1 | 364,700 | 120,000 |
2021-09-01 | 0.2683 | 11 | 41 | 23,124,699 | 22,429,105 |
Sight Sciences Notable Stakeholders
A Sight Sciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sight Sciences often face trade-offs trying to please all of them. Sight Sciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sight Sciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Alison Bauerlein | CFO Treasurer | Profile | |
Jim Rodberg | VP Controller | Profile | |
Steve Tamayo | VP Officer | Profile | |
MBA BS | VP Operations | Profile | |
Stacie Rodgers | VP HR | Profile | |
John Liu | VP Access | Profile | |
Stephen JD | Secretary | Profile | |
Reay MD | Chief Officer | Profile | |
Sam Park | Chief Officer | Profile | |
John Ordway | VP Operations | Profile | |
Brenton Taylor | Executive Operations | Profile | |
Matthew Link | Chief Officer | Profile | |
Jeremy JD | Chief Officer | Profile | |
Paul Badawi | President, CoFounder | Profile | |
Tom Huang | Head Development | Profile | |
Reay Brown | Chief Officer | Profile | |
David MD | CTO Founder | Profile | |
Jesse Selnick | Chief Officer | Profile | |
Jeremy Hayden | Chief Officer | Profile | |
Manohar Raheja | Executive Development | Profile |
About Sight Sciences Management Performance
The success or failure of an entity such as Sight Sciences often depends on how effective the management is. Sight Sciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sight management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sight management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.30) | (0.31) | |
Return On Capital Employed | (0.33) | (0.35) | |
Return On Assets | (0.30) | (0.31) | |
Return On Equity | (0.53) | (0.50) |
Please note, the imprecision that can be found in Sight Sciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sight Sciences. Check Sight Sciences' Beneish M Score to see the likelihood of Sight Sciences' management manipulating its earnings.
Sight Sciences Workforce Analysis
Traditionally, organizations such as Sight Sciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sight Sciences within its industry.Sight Sciences Manpower Efficiency
Return on Sight Sciences Manpower
Revenue Per Employee | 378.8K | |
Revenue Per Executive | 4.1M | |
Net Loss Per Employee | 259.6K | |
Net Loss Per Executive | 2.8M | |
Working Capital Per Employee | 703.8K | |
Working Capital Per Executive | 7.5M |
Additional Tools for Sight Stock Analysis
When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.